Activated regulatory T-cells (aTreg cells) were found to express high levels of CD39, CD73, and transforming growth factor beta (TGF-β).
Total Treg cells and aTreg cells decreased during antiviral therapy.
Targeting aTreg might be a future solution to prevent relapse of chronic hepatitis C.